[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Cancer Treatment Drugs Market Survey and Trend Research 2018

December 2017 | 143 pages | ID: GEBFA15ACABEN
99Strategy

US$ 2,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain
  • Raw Materials
  • Cost
  • Technology
  • Consumer Preference
Industry Overall:
  • History
  • Development & Trend
  • Market Competition
  • Trade Overview
  • Policy
Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):
  • Regional Market
  • Production Development
  • Sales
  • Regional Trade
  • Regional Forecast
Company (Roche, Novartis, Celgene, Amgen, Bristol-Myers Squibb, Bristol-Myers Squibb, Takeda, Eli Lilly, Pfizer, AstraZeneca, Astellas, Sanofi, Bayer, Merck & Co., Biogen Idec, Kyowa Hakko Kirin, Otsuka, Teva, Eisai, Merck KGaA, Ipsen, AbbVie, Gilead Sciences etc.):
  • Company Profile
  • Product & Service
  • Business Operation Data
  • Market Share
Investment Analysis:
  • Market Features
  • Investment Opportunity
  • Investment Calculation
1 PART 1 INDUSTRY OVERVIEW

1.1 Cancer Treatment Drugs Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

1 PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

1 PART 3 CANCER TREATMENT DRUGS MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Roche (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Novartis (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Celgene (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Amgen (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Bristol-Myers Squibb (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Bristol-Myers Squibb (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Takeda (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Eli Lilly (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Pfizer (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 AstraZeneca (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Astellas (Company Overview, Sales Data etc.)
4.12 Sanofi (Company Overview, Sales Data etc.)
4.13 Bayer (Company Overview, Sales Data etc.)
4.14 Merck & Co. (Company Overview, Sales Data etc.)
4.15 Biogen Idec (Company Overview, Sales Data etc.)
4.16 Kyowa Hakko Kirin (Company Overview, Sales Data etc.)
4.17 Otsuka (Company Overview, Sales Data etc.)
4.18 Teva (Company Overview, Sales Data etc.)
4.19 Eisai (Company Overview, Sales Data etc.)
4.20 Merck KGaA (Company Overview, Sales Data etc.)
4.21 Ipsen (Company Overview, Sales Data etc.)
4.22 AbbVie (Company Overview, Sales Data etc.)
4.23 Gilead Sciences (Company Overview, Sales Data etc.)

1 PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

1 PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

1 PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

1 PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

1 PART 9 CONCLUSION

LIST OF TABLES

Table Global Cancer Treatment Drugs Market 2012-2017, by Type, in USD Million
Table Global Cancer Treatment Drugs Market 2012-2017, by Type, in Volume
Table Global Cancer Treatment Drugs Market Forecast 2018-2023, by Type, in USD Million
Table Global Cancer Treatment Drugs Market Forecast 2018-2023, by Type, in Volume
Table Roche Overview List
Table Cancer Treatment Drugs Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Cancer Treatment Drugs Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Overview List
Table Cancer Treatment Drugs Business Operation of Celgene (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Cancer Treatment Drugs Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Cancer Treatment Drugs Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Cancer Treatment Drugs Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Overview List
Table Cancer Treatment Drugs Business Operation of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Cancer Treatment Drugs Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Cancer Treatment Drugs Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Cancer Treatment Drugs Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Overview List
Table Cancer Treatment Drugs Business Operation of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Cancer Treatment Drugs Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer Overview List
Table Cancer Treatment Drugs Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co. Overview List
Table Cancer Treatment Drugs Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biogen Idec Overview List
Table Cancer Treatment Drugs Business Operation of Biogen Idec (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kyowa Hakko Kirin Overview List
Table Cancer Treatment Drugs Business Operation of Kyowa Hakko Kirin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Otsuka Overview List
Table Cancer Treatment Drugs Business Operation of Otsuka (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Overview List
Table Cancer Treatment Drugs Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eisai Overview List
Table Cancer Treatment Drugs Business Operation of Eisai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck KGaA Overview List
Table Cancer Treatment Drugs Business Operation of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ipsen Overview List
Table Cancer Treatment Drugs Business Operation of Ipsen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Overview List
Table Cancer Treatment Drugs Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Sciences Overview List
Table Cancer Treatment Drugs Business Operation of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Cancer Treatment Drugs Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Cancer Treatment Drugs Sales Revenue Share, by Companies, in USD Million
Table Global Cancer Treatment Drugs Sales Volume 2012-2017, by Companies, in Volume
Table Global Cancer Treatment Drugs Sales Revenue Share, by Companies in 2017, in Volume
Table Cancer Treatment Drugs Demand 2012-2017, by Application, in USD Million
Table Cancer Treatment Drugs Demand 2012-2017, by Application, in Volume
Table Cancer Treatment Drugs Demand Forecast 2018-2023, by Application, in USD Million
Table Cancer Treatment Drugs Demand Forecast 2018-2023, by Application, in Volume
Table Global Cancer Treatment Drugs Market 2012-2017, by Region, in USD Million
Table Global Cancer Treatment Drugs Market 2012-2017, by Region, in Volume
Table Cancer Treatment Drugs Market Forecast 2018-2023, by Region, in USD Million
Table Cancer Treatment Drugs Market Forecast 2018-2023, by Region, in Volume

LIST OF FIGURES

Figure Cancer Treatment Drugs Industry Chain Structure
Figure Global Cancer Treatment Drugs Market Growth 2012-2017, by Type, in USD Million
Figure Global Cancer Treatment Drugs Market Growth 2012-2017, by Type, in Volume
Figure Global Cancer Treatment Drugs Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Cancer Treatment Drugs Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region


More Publications